-
Posted by
Two Blokes Jun 10 -
Filed in
Stock
-
9 views
Shares in Novo Nordisk (NYSE:NVO), maker of fat-busting jabs such as Ozempic, jumped 3% after the emergence of an activist investor on its share register. Parvus Asset Management is building a stake in the Danish drug giant, according to the Financial Times, amid investor unease over the company's position in the competitive weight-loss drug market.